CLINICAL_TRIALS
trial_result
· 2014-08-04
Clinical Trial Update: The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus [Phase 1]
Summary
Phase 1 clinical trial evaluating the safety and tolerability of Secretrol in patients with Barrett's Esophagus; current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Effexus Pharmaceutical | Conditions: Barrett's Esophagus | Phase 1 | Status: UNKNOWN